Literature DB >> 7653823

Nephrotoxicity in rats undergoing a one-hour exposure to compound A.

L Kandel1, M J Laster, E I Eger, R L Kerschmann, J Martin.   

Abstract

We previously demonstrated that rats experienced renal injury when exposed for 3-12 h to 50 ppm or more of a vinyl ether called Compound A [CF2 = C(CF3)OCH2F], a compound produced by CO2 absorbents acting on sevoflurane. These durations of exposure exceed the average duration of clinical anesthesia. We now report the effect of a 1-h exposure to 0, 100, 150, 200, 400, 600, or 800 ppm of Compound A in oxygen in 145 Wistar rats. Twenty-four hours after exposure, we obtained kidney and liver specimens for microscopic examination, applying hematoxylin and eosin, and (separately) an immunochemical marker (PCNA) for cell proliferation (regeneration). Compared with results from control rats (those breathing oxygen for 1 h), renal injury (defined as necrosis of the outer strip of the outer medullary layer or "corticomedullary junction necrosis") occurred at and above 200 ppm. Exposure to 150 ppm produced cell regeneration (i.e., stimulated cell proliferation). We conclude that the threshold concentrations for nephrotoxicity (i.e., minimal toxicity) for a 1-h exposure to Compound A exceed the maximum concentrations (particularly those at low inflow rates) reported in clinical practice by a factor of 2-3. If these threshold effects in rats apply to humans, one 1-h exposure to sevoflurane probably would not alter usual measures of renal function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7653823     DOI: 10.1097/00000539-199509000-00024

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  RE: Yuge O: Renal toxicity of compound A with sevoflurane anesthesia: the benefits of sevoflurane appear to outweight the risks (editorial).J. Anesth 11:1-2.

Authors:  Edmond I Eger; Jackie L Martin
Journal:  J Anesth       Date:  1997-12       Impact factor: 2.078

Review 2.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 3.  Modes of action of trichloroethylene for kidney tumorigenesis.

Authors:  L H Lash; J C Parker; C S Scott
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

4.  Performance of a new carbon dioxide absorbent, Yabashi lime® as compared to conventional carbon dioxide absorbent during sevoflurane anesthesia in dogs.

Authors:  Kei Kondoh; Ayman Atiba; Kiyoshi Nagase; Shizuko Ogawa; Takashi Miwa; Teruya Katsumata; Hiroshi Ueno; Yuji Uzuka
Journal:  J Vet Med Sci       Date:  2015-05-04       Impact factor: 1.267

5.  Investigation and Possibilities of Reuse of Carbon Dioxide Absorbent Used in Anesthesiology.

Authors:  Bartłomiej Rogalewicz; Agnieszka Czylkowska; Piotr Anielak; Paweł Samulkiewicz
Journal:  Materials (Basel)       Date:  2020-11-09       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.